Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics

被引:4
|
作者
Nakagomi, Ryo [1 ]
Tateishi, Ryosuke [1 ]
Mikami, Shintaro [1 ]
Wake, Taijiro [1 ]
Kinoshita, Mizuki Nishibatake [1 ]
Nakatsuka, Takuma [1 ]
Minami, Tatsuya [1 ]
Sato, Masaya [1 ]
Uchino, Koji [1 ]
Enooku, Kenichiro [1 ]
Nakagawa, Hayato [1 ]
Asaoka, Yoshinari [2 ]
Shiina, Shuichiro [3 ]
Koike, Kazuhiko [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[2] Teikyo Univ, Dept Med, Sch Med, Tokyo, Japan
[3] Juntendo Univ Hosp, Dept Gastroenterol, Tokyo, Japan
来源
PLOS ONE | 2021年 / 16卷 / 11期
关键词
PERCUTANEOUS-ETHANOL-INJECTION; SURGICAL SITE INFECTION; HEPATOCELLULAR-CARCINOMA; THERAPY; CIRRHOSIS; COAGULATION; PREVENTION; GUIDELINE; RATES;
D O I
10.1371/journal.pone.0259641
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and aim Prophylactic administration of antibiotics within 24 hours of surgery is recommended to reduce the risk of infection. We conducted a prospective study to compare the efficacy of single administration of antibiotics with a historical control of continuous administration of antibiotics for radiofrequency ablation (RFA) of malignant liver tumors. Methods Between February 1, 1999 and November 30, 2010, a total of 6,763 RFA treatments were performed in 2,355 patients, using a protocol with continuous administration of prophylactic antibiotics. On December 1, 2010, we began using a revised protocol with a single administration of prophylactic antibiotics, while continuing to use the old continuous administration protocol for patients who declined the new protocol. Interim analysis was performed to assess the safety of the single administration protocol. Thereafter, from April 1, 2012, all patients were treated using the new protocol. Risk factors for infectious complications of RFA were assessed using logistic regression. Results From December 2010 to March 2012, 766 RFA treatments were performed in 663 patients using the new antibiotic protocol. Infectious complications were observed following 4 of these treatments (0.52%). As the upper limit of the confidence interval (CI) resulting from a one-sided binomial test was exactly the prespecified limit of 1.0%, from April 2012 onwards, we treated all patients using the new protocol with single administration of prophylactic antibiotics. A total of 3,547 RFA treatments were performed using the single administration protocol. Univariable logistic regression indicated that prior transcatheter arterial chemoembolization (TACE) and maximal tumor diameter were significant risk factors for infectious complications (P = 0.04 and P < 0.001, respectively). Multivariable analysis indicated that the adjusted hazard ratio of single vs. continuous administration of antibiotics was 1.20 (95% CI: 0.53-2.75; P = 0.66). Conclusions The rate of infectious complications related to RFA was acceptably low. Single administration of prophylactic antibiotics did not significantly increase the rate of infectious complications related to RFA, compared with a more intensive antibiotic protocol.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Complications of percutaneous radiofrequency ablation of liver tumors
    De Baere, TJ
    Smayra, T
    Kuoch, V
    Dromain, C
    Girish, BV
    Roche, AJ
    [J]. RADIOLOGY, 2001, 221 : 627 - 627
  • [2] Complications from radiofrequency ablation of liver tumors.
    Zagoria, RJ
    Chen, MY
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1419 - A1419
  • [3] Hemorrhagic Complications of Percutaneous Radiofrequency Ablation for Liver Tumors
    Goto, Eriko
    Tateishi, Ryosuke
    Shiina, Shuichiro
    Masuzaki, Ryota
    Enooku, Kenichiro
    Sato, Takahisa
    Ohki, Takamasa
    Kondo, Yuji
    Goto, Tadashi
    Yoshida, Haruhiko
    Omata, Masao
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (05) : 374 - 380
  • [4] Early complications of radiofrequency ablation of liver tumors in the Netherlands.
    Jansen, MC
    van Duijnhoven, FH
    Fioole, B
    van Hillegersberg, R
    Rijken, AM
    van Coevorden, F
    van der Sijp, JR
    Tollenaar, RAEM
    Rinkes, IHB
    Klaase, JM
    Slooter, G
    van Gulik, TM
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A14 - A15
  • [5] Radiofrequency ablation of liver tumors
    Chong, WK
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (05) : 372 - 374
  • [6] Radiofrequency ablation of liver tumors
    Strasberg, SM
    Linehan, D
    [J]. CURRENT PROBLEMS IN SURGERY, 2003, 40 (08)
  • [7] Radiofrequency Ablation of Liver Tumors
    McDermott, Shaunagh
    Gervais, Debra A.
    [J]. SEMINARS IN INTERVENTIONAL RADIOLOGY, 2013, 30 (01) : 49 - 55
  • [8] Managing hemorrhagic complications after radiofrequency ablation therapy for liver tumors
    Goto, Eriko
    Tateishi, Ryosuke
    Shiina, Shuichiro
    Sato, Takahisa
    Ohki, Takamasa
    Masuzaki, Ryota
    Imamura, Jun
    Goto, Tadashi
    Yoshida, Hideo
    Kanai, Fumihiko
    Hamamura, Keisuke
    Yoshida, Haruhiko
    Omata, Masao
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A824 - A824
  • [10] Risk Factors for Hemorrhagic Complications After Radiofrequency Ablation Therapy for Liver Tumors
    Goto, Eriko
    Tateishi, Ryosuke
    Shiina, Shuichiro
    Enooku, Kenichito
    Sato, Takahisa
    Ohki, Takamasa
    Masuzaki, Ryota
    Imamura, Jun
    Kondo, Yuji
    Goto, Tadashi
    Yoshida, Haruhiko
    Omata, Masao
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A862 - A862